IL134778A0 - Pharmaceutical compositions for oral administration of molecular iodine - Google Patents

Pharmaceutical compositions for oral administration of molecular iodine

Info

Publication number
IL134778A0
IL134778A0 IL13477898A IL13477898A IL134778A0 IL 134778 A0 IL134778 A0 IL 134778A0 IL 13477898 A IL13477898 A IL 13477898A IL 13477898 A IL13477898 A IL 13477898A IL 134778 A0 IL134778 A0 IL 134778A0
Authority
IL
Israel
Prior art keywords
iodine
mammal
molecular iodine
molecular
pharmaceutical compositions
Prior art date
Application number
IL13477898A
Other languages
English (en)
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of IL134778A0 publication Critical patent/IL134778A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13477898A 1997-10-29 1998-10-21 Pharmaceutical compositions for oral administration of molecular iodine IL134778A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (1)

Publication Number Publication Date
IL134778A0 true IL134778A0 (en) 2001-04-30

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13477898A IL134778A0 (en) 1997-10-29 1998-10-21 Pharmaceutical compositions for oral administration of molecular iodine

Country Status (17)

Country Link
US (1) US5885592A (de)
EP (1) EP1024815B1 (de)
JP (1) JP4187410B2 (de)
KR (1) KR100412219B1 (de)
CN (1) CN1150904C (de)
AT (1) ATE231725T1 (de)
AU (1) AU750627B2 (de)
BR (1) BR9812588A (de)
CA (1) CA2301503C (de)
DE (1) DE69811105T2 (de)
DK (1) DK1024815T3 (de)
ES (1) ES2191973T3 (de)
IL (1) IL134778A0 (de)
NO (1) NO20001673L (de)
PT (1) PT1024815E (de)
RU (1) RU2213564C2 (de)
WO (1) WO1999021567A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
EP1044689A4 (de) * 1998-01-06 2002-07-03 Fujisawa Pharmaceutical Co Feste jodophorzusammensetzungen und verfahren zur ihrer herstellung
EP1087800B1 (de) * 1998-06-19 2003-08-06 Oxibio, Inc. Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
AU2004249301B2 (en) * 2003-06-20 2011-01-20 Hill's Pet Nutrition, Inc. Methods for hyperthyroidism in a cat and composition comprising limited iodine
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
DK2666366T3 (en) * 2006-01-26 2015-04-13 Hills Pet Nutrition Inc METHODS AND COMPOSITIONS FOR TREATING FELIN HYPERTHYROIDISM
AU2007249806B2 (en) * 2006-05-12 2011-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
ES2402077T3 (es) * 2006-07-03 2013-04-26 Hill's Pet Nutrition, Inc. Composiciones y métodos para la prevención o el tratamiento de enfermedades cardiovasculares en felinos con hipertiroidismo
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
WO2012158002A1 (ru) * 2011-05-16 2012-11-22 Begaliev Shokan Sabirkhanovich Лекарственный препарат «renessans», обладающий антибактериальным, противоязвенным и иммуномодулирующим действием
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
WO2015080984A1 (en) * 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
NZ721500A (en) 2014-02-10 2022-11-25 Fred Hutchinson Cancer Center Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury
CR20160499A (es) * 2014-03-31 2016-12-05 Iotech Int Inc Composiciones estables de yodo no en complejo y métodos de uso
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
CN110072532A (zh) 2016-07-21 2019-07-30 艾欧根有限责任公司 润肤局部消毒剂
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
TW202203900A (zh) * 2020-03-31 2022-02-01 越南商泰明製藥股份有限公司 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
AU750627B2 (en) 2002-07-25
DE69811105T2 (de) 2003-11-06
PT1024815E (pt) 2003-06-30
AU1122799A (en) 1999-05-17
CN1150904C (zh) 2004-05-26
WO1999021567A1 (en) 1999-05-06
EP1024815B1 (de) 2003-01-29
ES2191973T3 (es) 2003-09-16
CA2301503A1 (en) 1999-05-06
JP2003510243A (ja) 2003-03-18
EP1024815A1 (de) 2000-08-09
CA2301503C (en) 2005-01-04
US5885592A (en) 1999-03-23
RU2213564C2 (ru) 2003-10-10
ATE231725T1 (de) 2003-02-15
CN1272789A (zh) 2000-11-08
DK1024815T3 (da) 2003-05-19
DE69811105D1 (de) 2003-03-06
BR9812588A (pt) 2000-07-25
KR100412219B1 (ko) 2003-12-24
KR20010030861A (ko) 2001-04-16
NO20001673L (no) 2000-05-24
JP4187410B2 (ja) 2008-11-26
NO20001673D0 (no) 2000-03-31

Similar Documents

Publication Publication Date Title
IL134778A0 (en) Pharmaceutical compositions for oral administration of molecular iodine
EP0699072A4 (de) Eisenbindende polymere zur oralen verabreichung
EP1001772A4 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
GEP20022784B (en) Celecoxib Composition
PT906106E (pt) Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca)
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
EP1007055A4 (de) Methode zur verabreichung von amifostin
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP1064950A4 (de) Arzneimittel gegen hepatitis
EP1073436A4 (de) Verbesserte methode zur ausrottung von helicobacter pylori
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
EP0835662A3 (de) Arzneimittel zur Behandlung von Krebs
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections
EP1019066A4 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
YU28700A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
AU1305999A (en) (+)-ephedrine as a sympathomimetic drug
UA10436A (uk) Спосіб лікуваhhя виразкової хвороби шлуhку та дваhадцятипалої кишки
UA22191A (uk) Спосіб корекції моторhої фуhкції шлуhка і дваhадцятіпалої кишки після резекції шлуhка і ваготомії
UA10335A (uk) Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
ZA977873B (en) Dosage form and method for administering drug.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees